U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Pathogen: clinical or host-associated sample from Escherichia coli

Identifiers
BioSample: SAMN16304241; Sample name: Res13-Lact-PER13-36
Organism
Escherichia coli
cellular organisms; Bacteria; Pseudomonadati; Pseudomonadota; Gammaproteobacteria; Enterobacterales; Enterobacteriaceae; Escherichia
Package
Pathogen: clinical or host-associated; version 1.0
Attributes
collected byAgriculture and Agri-Food Canada
collection date2017-03-27
geographic locationCanada: Quebec
isolation sourcefeces
latitude and longitudemissing
hostSus scrofa domesticus
host diseasemissing
serotypeO167 (99.37):H26 (98.63)
strainRes13-Lact-PER13-36
BioProject
PRJNA662792 Escherichia coli
Retrieve all samples from this project

Submission
Agriculture and Agri-Food Canada, Jean-Simon Brouard; 2020-09-30
Antibiogram
AntibioticResistance phenotypeMeasurement signMeasurementMeasurement unitsLaboratory typing methodLaboratory typing platformVendorLaboratory typing method version or reagentTesting standard
ampicillinresistant>32mg/LMICSensititerCLSI
azithromycinsusceptible==4mg/LMICSensititerCLSI
cefoxitinsusceptible==8mg/LMICSensititerCLSI
ceftriaxoneresistant==32mg/LMICSensititerCLSI
chloramphenicolsusceptible==8mg/LMICSensititerCLSI
ciprofloxacinsusceptible<=1mg/LMICSensititerCLSI
gentamicinsusceptible<=4mg/LMICSensititerCLSI
meropenemsusceptible<=1mg/LMICSensititerCLSI
nalidixic acidsusceptible==4mg/LMICSensititerCLSI
streptomycinsusceptible==8mg/LMICSensititerCLSI
sulfisoxazoleresistant>256mg/LMICSensititerCLSI
tetracyclinesusceptible<=4mg/LMICSensititerCLSI
amoxicillin-clavulanic acidsusceptible==8/1mg/LMICSensititerCLSI
piperacillin-tazobactamsusceptible<=4/1mg/LMICSensititerCLSI
cefazolinresistant>16mg/LMICSensititerCLSI
cephalothinresistant>16mg/LMICSensititerCLSI
cefotaximeresistant==32mg/LMICSensititerCLSI
cefpodoximeresistant>32mg/LMICSensititerCLSI
ceftazidimeresistant==2mg/LMICSensititerCLSI
cefotaxime-clavulanic acidnot defined<=0.12/1mg/LMICSensititerCLSI
ceftazidime-clavulanic acidnot defined==0.25/1mg/LMICSensititerCLSI
cefepimesusceptible-dose dependent==4mg/LMICSensititerCLSI
imipenemsusceptible<=0.5mg/LMICSensititerCLSI
trimethoprim-sulfamethoxazoleresistant>4/1mg/LMICSensititerCLSI
Accession:
SAMN16304241
ID:
16304241

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center